I can only agree with Ioannis! Thank you Luca Cindolo Dr. Giovanni Ferrari for a great meeting on all levels! It was an honor to be on a panel with all the masters in the field.

🧬🔬 New Study Alert! In Europe, prostate cancer is the leading cancer among men. A recent systematic review highlights the cost-effectiveness of PCa screening programs. Findings suggest risk-based screening followed by MRI is a promising strategy. 📉📈 #ProstateCancer

🎉 Exciting news! The PCAN Journal has achieved a remarkable milestone with its new impact factor! 🌟 This is a testament to the hard work and dedication of our contributors, reviewers, and readers. Let's celebrate this achievement! 📚✨ #PCANImpactFactor #ResearchExcellence

🚨Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve #ProstateCancer🚨 Our work in European Urology was just published! 🔗authors.elsevier.com/a/1jndX14kplyz… 🧵 (1/18) @RobertReiterMD Boutros Lab Jeremie Calais UCLA Urology UCLA Health Cedars-Sinai Academic Medicine

Congratulations to the trial ! Even if infection for transrectal bx is low, needing no antibiotics and having no infections is a strong case for transperineal. If you can do better why not do it ? Karsten Guenzel Jan Philipp Radtke Hashim U. Ahmed Giovanni Lughezzani

On my way and excited for #emuc24 in Lisbon. I will present on the interim analysis of the OPTIMUM TRIAL on micro US! Looking to seeing friends and colleagues. European Association of Urology (EAU) Veeru Kasi Giovanni Lughezzani francescosanguedolce Gianluca Giannarini Cosimo De Nunzio

Thank you Veeru! Glad the tease worked out 😉

Wir haben eine freie Stelle für eine Fachärztin/Facharzt für Urologie in unserer Praxis in Charlottenburg. Frei ab Anfang 2025! Kontakt per hier oder via Indeed de.indeed.com/q-arzt-urologi…

There was a recent trial in the New England Journal of Medicine on this! In a new video in our partnership with Dr. Glaucomflecken, research into screening for prostate cancer with PSA and MRI is discussed: tiktok.com/@nejm.org/vide…

Transperineal biopsy had similar cancer detection rates as transrectal biopsy, but there were no infections after transperineal biopsy, this study found. ja.ma/3ZajVjc Jim Hu

Men with clinically suspected prostate cancer and negative MRI results can safely avoid biopsies with appropriate monitoring, validating the high negative predictive value of prebiopsy MRI in community healthcare settings. ja.ma/41vdL02

Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected #ProstateCancer jamanetwork.com/journals/jamao… This cohort study assessed the safety of omitting prostate biopsy (PB) in men with suspected prostate cancer who had negative multiparametric MRI (mpMRI)

Proud to share our JAMA Oncology study validating the oncological safety of MRI-guided biopsy decisions in suspected #ProstateCancer. A true honor to work with Patrick Asbach Ivo Schoots Veeru Kasi Hannes Cash on this 3-year monitoring study. Charité - Universitätsmedizin Berlin ja.ma/41vdL02

Happy to share our commentary led by Anwar Padhani on the PROKOMB trial, shorturl.at/gCWSz discussing: 1⃣Long-term safety of avoided Bx: MRI(-)👉≥GG2 4% @3yr) 2⃣Risk stratification 3⃣High-quality reporting 4⃣Re-thinking guidelines 5⃣Implications for AI development #pcsm

Most viewed in the last 7 days from JAMA Oncology: Men with negative multiparametric MRI results avoiding biopsy were not at elevated risk of clinically significant prostate cancer. ja.ma/3BF8usc

I will not read or post on x any longer. Musk promoting AFD etc. is too much . Find me on Bluesky @cashhannes.bsky.social